Article Text
Statistics from Altmetric.com
Footnotes
Contributors The author is solely responsible for the design, draft, revision and final approval of the work. The author agrees to be accountable for all aspects of the work.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Map disclaimer The depiction of boundaries on the map(s) in this article does not imply the expression of any opinion whatsoever on the part of BMJ (or any member of its group) concerning the legal status of any country, territory, jurisdiction or area or of its authorities. The map(s) are provided without any warranty of any kind, either express or implied.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Commissioned. Externally peer reviewed by Colin Mumford, Edinburgh, UK and David Simpson, Edinburgh, UK.
Linked Articles
- Editors’ commentary
Read the full text or download the PDF:
Other content recommended for you
- Management soon after a stroke
- The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
- Blood pressure management in acute stroke
- Recent progress in drug treatment for acute stroke
- Management of acute ischemic stroke
- Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
- Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging
- European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion
- What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers
- Antithrombotic therapy for cerebrovascular disorders